Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

301.42
-6.5800-2.14%
Post-market: 301.420.00000.00%16:20 EDT
Volume:335.34K
Turnover:102.14M
Market Cap:13.60B
PE:12.01
High:313.35
Open:308.26
Low:301.23
Close:308.00
Loading ...

UTHR or ZTS: Which Is the Better Value Stock Right Now?

Zacks
·
08 Feb

UBS Adjusts Price Target on United Therapeutics to $460 From $475, Keeps Buy Rating

MT Newswires Live
·
07 Feb

United Therapeutics Completes Patient Enrollment for Another Trial of Idiopathic Pulmonary Fibrosis Treatment

MT Newswires Live
·
04 Feb

United Therapeutics Corporation's (NASDAQ:UTHR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.
·
04 Feb

BRIEF-United Therapeutics Fully Enrolls Teton 1 Study Of Inhaled Treprostinil For Idiopathic Pulmonary Fibrosis

Reuters
·
04 Feb

United Therapeutics: TETON 1 study of nebulized Tyvaso for IPF fully enrolled

TIPRANKS
·
04 Feb

United Therapeutics Corp - Top Line Data Expected in First Half of 2026

THOMSON REUTERS
·
04 Feb

United Therapeutics Corporation Announces Full Enrollment of the Teton 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
04 Feb

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Business Wire
·
04 Feb

BofA Adjusts Price Target on United Therapeutics to $328 From $327

MT Newswires Live
·
03 Feb

BRIEF-United Therapeutics Gets FDA Clearance for uKidney Xenotransplantation Clinical Trial

Reuters
·
03 Feb

United Therapeutics Corporation Announces FDA Clearance of Its Investigational New Drug Application for the Ukidney Xenotransplantation Clinical Trial

THOMSON REUTERS
·
03 Feb

United Therapeutics Corp - First Xenotransplant Expected Around Mid-Year 2025

THOMSON REUTERS
·
03 Feb

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

Business Wire
·
03 Feb

Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

Zacks
·
01 Feb

Drug Companies Raise Prices on More Than 800 Drugs in January -- Update

Dow Jones
·
29 Jan

BTIG Reaffirms Their Hold Rating on United Therapeutics (UTHR)

TIPRANKS
·
24 Jan

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
21 Jan

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks
·
20 Jan

Top Stock Reports for Tesla, Bank of America & Alibaba

Zacks
·
14 Jan